Mihael Polymeropoulos, Vanda Pharmaceuticals CEO

Van­da los­es Het­lioz patent court de­ci­sion, vows to ap­peal and ask for stay on Te­va, Apo­tex com­peti­tors

A fed­er­al judge in­val­i­dat­ed four of Van­da Phar­ma­ceu­ti­cals’ patents for sleep med Het­lioz on Tues­day, ef­fec­tive­ly open­ing the door to gener­ic tasimelteon com­pe­ti­tion from Te­va …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.